Primo Medda emerged from the innovative spirit of 4MedBox, stemming from the Personal Genetic Locker project, where we conducted a groundbreaking pharmacogenetic pilot in collaboration with Isala hospital. This unique fusion of technology and expertise enables us to forge new pathways in healthcare, particularly in times of crisis such as the war in Ukraine or the 2025 earthquake in Turkey. Here, the demand for personalised medicine is more urgent than ever, prompting us to join forces to ensure the accessibility of genetic information and treatments. With this knowledge, we aim not only to save lives but also to provide hope and recovery to those who need it most.